Search details
1.
Phase III study of cisplatin with or without S-1 in patients with stage IVB, recurrent, or persistent cervical cancer.
Br J Cancer
; 119(5): 530-537, 2018 08.
Article
in English
| MEDLINE | ID: mdl-30072745
2.
Phase II basket trial of perifosine monotherapy for recurrent gynecologic cancer with or without PIK3CA mutations.
Invest New Drugs
; 35(6): 800-812, 2017 12.
Article
in English
| MEDLINE | ID: mdl-28864978
3.
Feasibility study on combination chemotherapy using nogitecan hydrochloride (topotecan) and cisplatin for patients with metastatic, persistent, or recurrent uterine cervical cancer.
Int J Clin Oncol
; 21(5): 969-974, 2016 Oct.
Article
in English
| MEDLINE | ID: mdl-27142771
4.
Evaluation of human epididymis protein 4 (HE4) and Risk of Ovarian Malignancy Algorithm (ROMA) as diagnostic tools of type I and type II epithelial ovarian cancer in Japanese women.
Tumour Biol
; 36(2): 1045-53, 2015 Feb.
Article
in English
| MEDLINE | ID: mdl-25326813
5.
Performance of p16INK4a/Ki-67 immunocytochemistry for identifying CIN2+ in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion specimens: a Japanese Gynecologic Oncology Group study.
Int J Clin Oncol
; 20(1): 134-42, 2015 Feb.
Article
in English
| MEDLINE | ID: mdl-24744261
6.
Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial.
Lancet Oncol
; 14(10): 1020-6, 2013 Sep.
Article
in English
| MEDLINE | ID: mdl-23948349
7.
The use of HE4 in the prediction of ovarian cancer in Asian women with a pelvic mass.
Gynecol Oncol
; 128(2): 239-44, 2013 Feb.
Article
in English
| MEDLINE | ID: mdl-23063998
8.
Docetaxel/irinotecan combination chemotherapy in platinum/taxane-refractory and -resistant ovarian cancer: JGOG/WJGOG Intergroup Study.
Int J Clin Oncol
; 18(1): 126-31, 2013 Feb.
Article
in English
| MEDLINE | ID: mdl-22127346
9.
Feasibility study of paclitaxel plus carboplatin in patients with endometrial cancer: a Japan Kanto Tumor Board study (JKTB trial).
J Obstet Gynaecol Res
; 39(1): 311-6, 2013 Jan.
Article
in English
| MEDLINE | ID: mdl-22639962
10.
Risk factors of treatment discontinuation due to uterine bleeding in adenomyosis patients treated with dienogest.
J Obstet Gynaecol Res
; 38(4): 639-44, 2012 Apr.
Article
in English
| MEDLINE | ID: mdl-22413833
11.
Long-term survival in patients with clear cell adenocarcinoma of ovary treated with irinotecan hydrochloride plus cisplatin therapy as first-line chemotherapy.
J Obstet Gynaecol Res
; 38(12): 1367-75, 2012 Dec.
Article
in English
| MEDLINE | ID: mdl-22639843
12.
Pilot study of CD147 protein expression in epithelial ovarian cancer using monoclonal antibody 12C3.
J Obstet Gynaecol Res
; 38(9): 1211-9, 2012 Sep.
Article
in English
| MEDLINE | ID: mdl-22563698
13.
A phase II clinical trial of topotecan in Japanese patients with relapsed ovarian carcinoma.
Jpn J Clin Oncol
; 41(3): 320-7, 2011 Mar.
Article
in English
| MEDLINE | ID: mdl-20974678
14.
Does severe anemia caused by dose-dense paclitaxel-Carboplatin combination therapy have an effect on the survival of patients with epithelial ovarian cancer? Retrospective analysis of the Japanese gynecologic oncology group 3016 trial.
Int J Gynecol Cancer
; 21(9): 1585-91, 2011 Dec.
Article
in English
| MEDLINE | ID: mdl-22123713
15.
[Lymphedema].
Gan To Kagaku Ryoho
; 38(4): 528-33, 2011 Apr.
Article
in Japanese
| MEDLINE | ID: mdl-21498979
16.
Asian perspective on debulking surgery for advanced ovarian cancer: An E-survey.
Eur J Surg Oncol
; 47(5): 1111-1116, 2021 05.
Article
in English
| MEDLINE | ID: mdl-33303297
17.
Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial.
Lancet
; 374(9698): 1331-8, 2009 Oct 17.
Article
in English
| MEDLINE | ID: mdl-19767092
18.
Randomized phase II trial of paclitaxel plus carboplatin therapy versus irinotecan plus cisplatin therapy as first-line chemotherapy for clear cell adenocarcinoma of the ovary: a JGOG study.
Int J Gynecol Cancer
; 20(2): 240-7, 2010 Feb.
Article
in English
| MEDLINE | ID: mdl-20169667
19.
Evidence-based guidelines for treatment of uterine body neoplasm in Japan: Japan Society of Gynecologic Oncology (JSGO) 2009 edition.
Int J Clin Oncol
; 15(6): 531-42, 2010 Dec.
Article
in English
| MEDLINE | ID: mdl-21069552
20.
Evidence-based guidelines for treatment of cervical cancer in Japan: Japan Society of Gynecologic Oncology (JSGO) 2007 edition.
Int J Clin Oncol
; 15(2): 117-24, 2010 Apr.
Article
in English
| MEDLINE | ID: mdl-20333431